MCK McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.…
Industry Peers
Medical DistributionKey Statistics
About McKesson (NYSE: MCK)
›
McKesson (NYSE: MCK) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 41,600 employees.
The shares were at 1062.16 USD on 19 November 2026, up 26.4% over 52 weeks. Its 52-week range is 723.68 USD to 1121.50 USD: the price is 5.3% below the high and 46.8% above the low.
At a market capitalisation of 122.63B USD, it trades at 27.4 times trailing earnings and 20.2 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 20.3, a premium of 35% for MCK. It pays a dividend yielding 0.35% (it pays out 9% of its earnings), against a median of 2.55% among the dividend payers in that peer group.
McKesson reports return on equity of -219.2%, an operating margin of 1.6% and revenue up 7.6% year over year.
Its debt exceeds its cash by 4.67B USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 1161.07 USD is 9.3% above the current price. The next earnings report is expected on 3 February 2027.